Bill & Melinda Gates Foundation

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Bill & Melinda Gates Foundation reported 5 stock positions worth $43.5 million. Its top holding was Biontech SE-ADR (BNTX) at 40.6% of the portfolio, followed by Vir Biotechnology (VIR, 26.8%) and Exscientia (EXAI, 17.8%). Compared with Q2 2024, it reduced 1. The biggest sale was Curevac (CVAC, shares −2%).

Most Recent 13F
Q3 2024
Location
SEATTLE, WA
CIK
0001663801
Portfolio Value
$43.5M (Q3 2024)
SEC Filing
0000898432-24-000922 ↗ filed Nov 14, 2024

Holdings Value

0$20.0M$40.0M$60.0M$80.0M$100.0M Q1 2024: $84.1M Q1 2024 Q2 2024: $40.2M Q2 2024 Q3 2024: $43.5M $43.5M Q3 2024

Holdings 5 stocks · $43.5M
BNTX Biontech SE-ADR 40.59% 148,674 $17.7M No change
VIR Vir Biotechnology Inc. 26.84% 1,559,142 $11.7M No change
EXAI Exscientia Ltd. 17.85% 1,590,909 $7.8M No change
CVAC Curevac NV 10.60% 1,568,866 $4.6M Reduce -1.8%
BFLY Butterfly Network Inc. 4.11% 1,011,003 $1.8M No change

Portfolio Sells Q2 2024 → Q3 2024
CVAC Curevac NV Reduce -1.8% 10.60% −2.90

Portfolio Buys Q2 2024 → Q3 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2024 5$43.5MBNTX, VIR, EXAI, CVAC, BFLY
Q2 2024Amended 5$40.2MVIR, BNTX, EXAI, CVAC, BFLY
Q1 2024 8$84.1MIMCR, VIR, BNTX, EXAI, CVAC